688062 迈威生物
2026/06 - 中期
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额(508,938)(290,223)(956,444)(782,728)(719,171)
投资活动产生之现金流量净额(140,734)(199,315)(291,554)(509,623)(602,803)
筹资活动产生之现金流量净额1,434,501791,925831,698444,9363,715,810
汇率变动对现金及现金等价物的影响(17,236)(3,614)2331,4032,264
现金及现金等价物净增加/(减少)767,593298,773(416,067)(846,011)2,396,100
期初现金及现金等价物余额1,526,3391,227,5661,643,6332,489,64593,545
期末现金及现金等价物余额2,293,9321,526,3391,227,5661,643,6332,489,645